Screener
Hemab Therapeutics Holdings, Inc. COAG Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q2 '25 | ||
|---|---|---|---|---|---|
| Liquidity | |||||
| Current ratio | 35.8×— | 12.8×— | 18×— | —— | |
| Leverage | |||||
| Debt-to-equity | 0×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $15.09+110% | -$209.96-53.8% | —— | -$149.55— | |
| Valuation | |||||
| Market capitalization | $2.32B+107% | —— | —— | —— | |
| Price / book | 5.1×— | —— | —— | —— |
FAQ
- Where do Hemab Therapeutics Holdings, Inc.'s ratios come from?
- Every ratio is computed from Hemab Therapeutics Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.